Skip to content
Moxifloxacin
Moxeza, Vigamox (moxifloxacin) is a small molecule pharmaceutical. Moxifloxacin was first approved as Avelox on 1999-12-10. It is used to treat bacterial infections, bacterial pneumonia, bacteroides infections, bronchitis, and cystitis amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
otorhinolaryngologic diseasesD010038
urogenital diseasesD000091642
Trade Name
FDA
EMA
Moxeza, Vigamox (generic drugs available since 2014-02-18, discontinued: Avelox)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Moxifloxacin hydrochloride
Tradename
Company
Number
Date
Products
MOXIFLOXACIN HYDROCHLORIDEFresenius KabiN-205572 RX2015-04-03
1 products, RLD, RS
MOXEZAHarrowN-022428 RX2010-11-19
1 products, RLD, RS
VIGAMOXNovartisN-021598 RX2003-04-15
1 products, RLD, RS
Show 2 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
aveloxNew Drug Application2011-12-13
moxeza New Drug Application2020-10-02
moxifloxacin hydrochlorideANDA2023-06-05
vigamoxNew Drug Application2022-07-12
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infections—D001424A49
bacterial pneumoniaEFO_1001272D018410J15.9
bacteroides infectionsEFO_1000832D001442—
bronchitis—D001991J40
cystitisEFO_1000025D003556N30
escherichia coli infectionsEFO_1001318D004927B96.20
gonorrheaDOID_7551D006069A54
haemophilus infectionsEFO_1001127D006192—
klebsiella infectionsEFO_1001353D007710—
proteus infectionsEFO_1001130D011512—
Show 8 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Moxifloxacin Hydrochloride, Moxeza, Harrow Eye
84503112029-05-29DP
91141682029-05-29DP
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01M: Quinolone antibacterials
— J01MA: Fluoroquinolone antibacterials, systemic
— J01MA14: Moxifloxacin
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AE: Fluoroquinolone antiinfectives, ophthalmologic
— S01AE07: Moxifloxacin
HCPCS
Code
Description
J2280
Injection, moxifloxacin, 100 mg
Clinical
Clinical Trials
19 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OnchocerciasisD009855EFO_0007402B73123——6
InfectionsD007239EFO_0000544222——5
TrichuriasisD014257EFO_0007524B79—22——3
AscariasisD001196EFO_0007154B77—12——2
Hookworm infectionsD006725EFO_0007314B76—12——2
Filarial elephantiasisD004605EFO_0007272B74.0——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
LoiasisD008118B74.3—1———1
Ocular onchocerciasisD015827EFO_0007398B73—1———1
ScabiesD012532B86—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMOXIFLOXACIN
INNmoxifloxacin
Description
Moxifloxacin is a quinolone that consists of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid bearing a cyclopropyl substituent at position 1, a fluoro substitiuent at position 6, a (4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl group at position 7 and a methoxy substituent at position 8. A member of the fluoroquinolone class of antibacterial agents. It has a role as an antibacterial drug. It is a quinolinemonocarboxylic acid, a quinolone, a member of cyclopropanes, a pyrrolidinopiperidine, an aromatic ether, a quinolone antibiotic and a fluoroquinolone antibiotic. It is a conjugate base of a moxifloxacinium(1+).
Classification
Small molecule
Drug classantibacterials (quinolone derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12
Identifiers
PDB—
CAS-ID151096-09-2
RxCUI139462
ChEMBL IDCHEMBL32
ChEBI ID63611
PubChem CID152946
DrugBankDB00218
UNII IDU188XYD42P (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 20,214 documents
View more details
Safety
Black-box Warning
Black-box warning for: Avelox, Moxifloxacin hydrochloride
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
1 adverse events reported
View more details